Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.26.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.10.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBTNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CL.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBMNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.4.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.501NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.226NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.546NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.194NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.429.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.9 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.25.1.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.203NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.157NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.176NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.3.4 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.391NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.393NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.432NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.388NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.48NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.112NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.515NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.370NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.118NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.137NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used